116 related articles for article (PubMed ID: 6105195)
1. Tiapride binds to mouse striatal tissue pre-exposed to dopamine stimulation.
Fortune DH; Costall B; Naylor RJ
J Pharm Pharmacol; 1980 Jul; 32(7):514-7. PubMed ID: 6105195
[No Abstract] [Full Text] [Related]
2. Comparison of effects of tiapride and sulpiride on D-1, D-2, D-3 and D-4 subtypes of dopamine receptors in rat striatal and bovine caudate nucleus membranes.
Arima T; Samura N; Nomura Y; Segawa T
Jpn J Pharmacol; 1986 Jul; 41(3):419-23. PubMed ID: 3761757
[TBL] [Abstract][Full Text] [Related]
3. Effects of repeated tiapride administration on anterior pituitary dopamine receptors and prolactin release in the rat.
Apud JA; Masotto C; Monopoli A; Ongini E; Rovescalli AC; Racagni G
Pharmacol Res Commun; 1987 Feb; 19(2):119-29. PubMed ID: 3588649
[TBL] [Abstract][Full Text] [Related]
4. A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.
Jenner P; Elliott PN; Clow A; Reavill C; Marsden CD
J Pharm Pharmacol; 1978 Jan; 30(1):46-8. PubMed ID: 22724
[No Abstract] [Full Text] [Related]
5. Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors.
Hermesh H; Huberman M; Radvan H; Kott E
J Nerv Ment Dis; 1984 Nov; 172(11):692-5. PubMed ID: 6238132
[TBL] [Abstract][Full Text] [Related]
6. Characterization of sulpiride-displaceable 3H-YM-09151-2 binding sites in rat frontal cortex and the effects of subchronic treatment with haloperidol on cortical D-2 dopamine receptors.
Kazawa T; Mikuni M; Higuchi T; Arai I; Takahashi K; Yamauchi T
Life Sci; 1990; 47(6):531-7. PubMed ID: 2402179
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of tiapride in patients with tardive dyskinesia and Huntington's disease.
Roos RA; de Haas EJ; Buruma OJ; de Wolff FA
Eur J Clin Pharmacol; 1986; 31(2):191-4. PubMed ID: 2948825
[TBL] [Abstract][Full Text] [Related]
8. 3H-Haloperidol binding to dopamine receptors in rat corpus striatum: influence of chlorpromazine metabolites and derivatives.
Creese I; Manian AA; Prosser TD; Snyder SH
Eur J Pharmacol; 1978 Feb; 47(3):291-6. PubMed ID: 631182
[TBL] [Abstract][Full Text] [Related]
9. Dopamine efflux from striatum after chronic nicotine: evidence for autoreceptor desensitization.
Harsing LG; Sershen H; Lajtha A
J Neurochem; 1992 Jul; 59(1):48-54. PubMed ID: 1351932
[TBL] [Abstract][Full Text] [Related]
10. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum.
Friend WC; Brown GM; Jawahir G; Lee T; Seeman P
Am J Psychiatry; 1978 Jul; 135(7):839-41. PubMed ID: 665797
[TBL] [Abstract][Full Text] [Related]
11. Ontogenesis of dopamine receptor binding in the corpus striatum of the rat.
Pardo JV; Creese I; Burt DR; Snyder SH
Brain Res; 1977 Apr; 125(2):376-82. PubMed ID: 851885
[No Abstract] [Full Text] [Related]
12. [3H]haloperidol binding to more than one site in rat brain striatum.
Helmeste DM; Seeman P
Biochem Pharmacol; 1983 Feb; 32(4):741-4. PubMed ID: 6830638
[No Abstract] [Full Text] [Related]
13. The classification of dopamine receptors: relationship to radioligand binding.
Creese I; Sibley DR; Hamblin MW; Leff SE
Annu Rev Neurosci; 1983; 6():43-71. PubMed ID: 6220666
[No Abstract] [Full Text] [Related]
14. [3H]Haloperidol and [3H]spiroperidol binding in rat striatum during ageing.
Govoni S; Spano PF; Trabucchi M
J Pharm Pharmacol; 1978 Jul; 30(7):448-9. PubMed ID: 27613
[No Abstract] [Full Text] [Related]
15. Determination of dopamine D(4) receptor density in rat striatum using PB12 as a probe.
Colabufo NA; Berardi F; Calò R; Leopoldo M; Perrone R; Tortorella V
Eur J Pharmacol; 2001 Sep; 427(1):1-5. PubMed ID: 11553357
[TBL] [Abstract][Full Text] [Related]
16. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.
Köhler C; Hall H; Ogren SO; Gawell L
Biochem Pharmacol; 1985 Jul; 34(13):2251-9. PubMed ID: 4015674
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.
Creese I; Burt DR; Snyder SH
Science; 1977 Aug; 197(4303):596-8. PubMed ID: 877576
[TBL] [Abstract][Full Text] [Related]
18. [3H]dihydroergocryptine binding to bovine striatal membranes defined by a low d-butaclamol concentration: antagonism by substituted benzamides.
Lin CW; Maayani S; Wilk S
Biochem Pharmacol; 1981 Jun; 30(11):1305-14. PubMed ID: 6168265
[No Abstract] [Full Text] [Related]
19. 3[H]-Sulpiride labels mesolimbic non-dopaminergic sites that bind antidepressant drugs.
Csernansky JG; Csernansky CA; Hollister LE
Experientia; 1985 Nov; 41(11):1419-21. PubMed ID: 4065296
[TBL] [Abstract][Full Text] [Related]
20. [125I]iodopride: a specific high affinity radioligand for labelling striatal dopamine D-2 receptors.
Janowsky A; De Paulis T; Clanton JA; Smith HE; Ebert MH; Kessler RM
Eur J Pharmacol; 1988 May; 150(1-2):203-5. PubMed ID: 3402540
[No Abstract] [Full Text] [Related]
[Next] [New Search]
